Question 1

What is Sunlenca?

Accepted Answer

Sunlenca is an antiretroviral medication used in the management of human immunodeficiency virus type 1 (HIV-1). It belongs to a class of drugs known as capsid inhibitors.

This medication works by interfering with the HIV capsid, which is the protein shell that protects the virus's genetic material. By disrupting the viral lifecycle at multiple stages, it helps to block the virus from multiplying and decreases the amount of virus present in the body.

Question 2

What is Sunlenca used for?

Accepted Answer

Sunlenca is used to treat HIV-1 infection .

Question 3

How does Sunlenca work?

Accepted Answer

Mechanism of Action

Sunlenca (lenacapavir) belongs to a class of medications called HIV-1 capsid inhibitors. It works differently than many other antiretroviral drugs by targeting the HIV-1 capsid, which is the protective protein shell that surrounds the virus's genetic material.

By binding to this capsid, Sunlenca disrupts the HIV lifecycle at several different stages:

Nuclear Uptake: It blocks the virus from transporting its genetic material into the nucleus of the host cell, a step required for the virus to replicate.

Virus Assembly: It interferes with the process of building new virus particles within the host cell.

Capsid Maturation: It prevents the virus from forming a functional shell. This results in the production of immature, non-infectious virus particles that cannot spread to other cells.

Because Sunlenca targets the virus in a unique way, it can be effective for individuals whose HIV has developed resistance to other types of HIV medications. When used in combination with other antiretroviral therapies, it helps lower the amount of HIV in the blood (viral load) and supports the immune system.

Question 4

What are the active ingredients in Sunlenca?

Accepted Answer

The active ingredient in Sunlenca is lenacapavir .

Question 5

What are the side effects of Sunlenca?

Accepted Answer

Common side effects of Sunlenca may include:

injection site reactions

nausea

diarrhea

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Sunlenca?

Accepted Answer

Sunlenca belongs to the HIV-1 capsid inhibitor drug class.

Question 7

What is the dosage of Sunlenca and how do I take it?

Accepted Answer

Administration Method

Sunlenca treatment involves two phases: an initiation phase and a maintenance phase. During the initiation phase, you will take oral tablets and receive injections. Once the maintenance phase begins, the medication is administered only as an injection under the skin, typically in the abdomen.

The oral tablets can be taken with or without food. The injections must be administered by a healthcare professional in a medical setting.

Dosing Schedule

Initiation: Your healthcare provider will determine the specific starting schedule, which involves taking tablets over several days and receiving initial injections.

Maintenance: After the starting doses, you will receive injections once every six months.

Missed Doses

It is essential to receive your injections and take your tablets exactly as scheduled. If you miss an appointment for an injection or forget to take a dose of the tablets, contact your healthcare provider immediately to reschedule. Missing doses can make the virus harder to treat and may lead to drug resistance.

Question 8

Is Sunlenca safe during pregnancy and breastfeeding?

Accepted Answer

There are no adequate studies on the use of Sunlenca in pregnant individuals to determine if there is a drug-associated risk of birth defects or miscarriage. In animal studies, no significant developmental issues were observed at doses much higher than those used in humans. Because Sunlenca stays in the body for a long time after the last dose, its effects during pregnancy may persist even after treatment is stopped.

If you are pregnant or planning to become pregnant, discuss the potential risks and benefits of this medication with your healthcare provider.

It is not known whether Sunlenca passes into human breast milk or if it affects a nursing infant. However, health experts generally recommend that individuals with HIV do not breastfeed to avoid the risk of transmitting the virus to the baby. Additionally, there is a risk that the infant could develop viral resistance if the medication is present in breast milk.

Question 9

What forms and strengths does Sunlenca come in?

Accepted Answer

Sunlenca is provided in the following forms:

Oral Tablets: These are taken by mouth, typically during the initial phase of treatment.

Subcutaneous Injection: This is a long-acting formulation administered by a healthcare professional under the skin.

Question 10

What is the FDA approval status of Sunlenca?

Accepted Answer

FDA Approval Status

The U.S. Food and Drug Administration (FDA) approved Sunlenca in December 2022. It is the first medication in a class of drugs known as capsid inhibitors to be approved for the treatment of HIV-1.

Approved Indications

Sunlenca is specifically indicated for adults with HIV-1 infection who meet the following criteria:

They are heavily treatment-experienced, meaning they have a history of taking multiple HIV medications.

Their HIV-1 infection is multi-drug resistant, making it difficult to treat with standard regimens.

Their current antiretroviral treatment is failing due to resistance, safety concerns, or intolerance.

This medication is not a standalone cure or treatment; it must be used as part of a combination regimen with other antiretroviral drugs.

Regulatory Considerations

The FDA approval was based on clinical evidence showing the drug's effectiveness in reducing viral loads in patients who had exhausted other treatment options. There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) associated with Sunlenca. During the regulatory process, the FDA previously addressed concerns regarding the compatibility of the injectable formulation with certain glass vials, which was resolved prior to the drug's final approval and release.

Question 11

What should I know about Sunlenca and cost?

Accepted Answer

Insurance and Prior Authorization

Sunlenca is a specialty medication used for adults with multi-drug resistant HIV-1. Most insurance providers require prior authorization, a process where your doctor must prove the medical necessity of the drug before the plan agrees to cover it. Your out-of-pocket costs, such as copays or coinsurance, will vary based on your specific insurance plan.

Cost of Administration

The total cost of treatment includes both the medication and its administration. Sunlenca involves two different forms of the drug:

Initial Dosing: A series of oral tablets taken at the start of treatment.

Maintenance Dosing: Subcutaneous injections administered by a healthcare professional every six months.

Because the maintenance doses must be given by a healthcare provider, you may incur costs for the healthcare provider's time and the medical facility in addition to the price of the drug itself.

Financial Support Options

Financial assistance may be available through the manufacturer for eligible patients. These programs often include copay cards for those with private insurance or patient assistance programs for those who are uninsured or have limited coverage. You can ask your healthcare provider or pharmacist for help identifying these resources.

Sunlenca

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?